Summary
Signal counts
Assets tracked: 1
Watchlist assets: 1
Registry stop assets: 0
Sponsor overview
Hallym University Medical Center
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT01046461
Assets
Linked programs
- Ramosetron, Aprepitant, Dexamethasone: Timeline Staleness Signal (3/5)